Annual Drug Patent Expirations for MACRILEN
Macrilen is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug.
This drug has sixty-four patent family members in thirty-one countries.
The generic ingredient in MACRILEN is macimorelin acetate. Two suppliers are listed for this compound. Additional details are available on the macimorelin acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
